Search Results - "Van Nuys, K."

The impact of broader hepatitis C treatment strategies on population health and social value in England by Van Nuys, K, Chou, J.W, Silverstein, A, Brookmeyer, R, Goldman, D.P

Get full text

P6 The Effect of Formulary Restrictions on the Disease Outcomes Among Medicare Beneficiaries With Multiple Sclerosis in the United States by Chen, J., Van Nuys, K., Blaylock, B., Wu, J., Joyce, G.

Get full text

LIFETIME BENEFITS OF IMPROVED HEART FAILURE TREATMENT AMONG OLDER AMERICANS by Xie, Z, Van Nuys, K, Tysinger, B

“…OBJECTIVES: Lifetime Benefits of Improved Heart Failure Treatment Among Older Americans METHODS: We adapted an established economic-demographic microsimulation…”
Get full text

PCV36 The Future Burden of Heart Disease in Europe, JAPAN, and the United States by Atella, V., Belotti, F., Chapel, J., Hashimoto, H., Kasajima, M., Peneva, D., Piano Mortari, A., Tysinger, B., Van Nuys, K.

Get full text

FRI-462 - The impact of broader hepatitis C treatment strategies on population health and social value in England by Van Nuys, K., Chou, J.W., Silverstein, A., Brookmeyer, R., Goldman, D.P.

Get full text

Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access: Case of PCSK9 Inhibitors by Cheng, W, Hlavka, JP, Snowberg, E, Van Nuys, K, Goldman, DP

Get full text

PCV74 - Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access: Case of PCSK9 Inhibitors by Cheng, W, Hlavka, JP, Snowberg, E, Van Nuys, K, Goldman, DP

Get full text

Value of Expanding Hcv Treatment Capacity in Germany Through Novel, Effective and Shorter Duration Therapies by Sbarigia, U, Wirth, D, Van Nuys, K, Huber, C, Brookmeyer, R, Stahmeyer, J, Krauth, C

Get full text

PIN88 - Value of Expanding Hcv Treatment Capacity in Germany Through Novel, Effective and Shorter Duration Therapies by Sbarigia, U, Wirth, D, Van Nuys, K, Huber, C, Brookmeyer, R, Stahmeyer, J, Krauth, C

Get full text

The passive-aggressive organization by Kaplan, Robert S, Norton, David P

“…Passive-aggressive organizations are friendly places to work: People are congenial, conflict is rare, and consensus is easy to reach. But, at the end of the…”
Get more information

Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions

“…[...]shortages are getting worse. [...]if the generic manufacturers from the developing countries can be the direct suppliers to the developing countries there…”
Get full text